We are live on !
Find out more
Fagan Associates Portfolio holdings
AUM
$861M
Turnover
5.63%
1-Year Est. Return
31.91%
This Fund
S&P 500
This Quarter Est. Return
+4.83%
1 Year Est. Return
+31.91%
3 Year Est. Return
+126.69%
5 Year Est. Return
+149.41%
10 Year Est. Return
+595.96%
AUM
$428M
AUM Growth
+$29.5M
(+7.4%)
Cap. Flow
+$17M
Cap. Flow % of AUM
Cap. Flow %
3.98%
Top 10 Holdings %
Top 10 Hldgs %
39.79%
Holding
127
New
11
Increased
41
Reduced
59
Closed
2
Avg Time Held
3
years
Top 10 Avg Time Held
3
years
Top 20 Avg Time Held
3.6
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ally Financial
ALLY
|
+$3.75M |
| 2 |
Vertex Pharmaceuticals
VRTX
|
+$3.2M |
| 3 |
General Motors
GM
|
+$3.17M |
| 4 |
Teladoc Health
TDOC
|
+$3.14M |
| 5 |
AT&T
T
|
+$2.87M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ulta Beauty
ULTA
|
+$3.93M |
| 2 |
UnitedHealth
UNH
|
+$3.81M |
| 3 |
KL
Kirkland Lake Gold Ltd Ordinary
KL
|
+$2.61M |
| 4 |
Schwab US Large-Cap Growth ETF
SCHG
|
+$2.19M |
| 5 |
Meta Platforms (Facebook)
META
|
+$2.17M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 23.91% |
| 2 | Technology | 21.61% |
| 3 | Consumer Discretionary | 16.76% |
| 4 | Communication Services | 13.09% |
| 5 | Financials | 12.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
VAR
101
DELISTED
Varian Medical Systems, Inc.
VAR
| $353K | 0.08% |
2,000
| – | – |
2014 Q1
28 quarters
|
|
102
SPDR Gold Trust
GLD
$141B
| $351K | 0.08% |
2,192
| – | – |
2020 Q3
2 quarters
|
|
103
Schwab US Large- Cap ETF
SCHX
$73.7B
| $336K | 0.08% |
21,024
-858
| -4% | -$13.4K |
2019 Q1
8 quarters
|
|
104
ExxonMobil
XOM
$736B
| $336K | 0.08% |
6,023
+9
| +0.1% | +$472 |
2014 Q1
28 quarters
|
|
105
Procter & Gamble
PG
$370B
| $328K | 0.08% |
2,423
-100
| -4% | -$13K |
2019 Q3
6 quarters
|
|
106
Duke Energy
DUK
$94.7B
| $326K | 0.08% |
3,378
| – | – |
2019 Q3
6 quarters
|
|
107
Comcast
CMCSA
$77.7B
| $322K | 0.08% |
5,957
-96
| -2% | -$5.07K |
2019 Q1
8 quarters
|
|
108
Dominion Energy
D
$55.9B
| $305K | 0.07% |
4,018
| – | – |
2019 Q3
6 quarters
|
|
109
Deere & Co
DE
$173B
| $299K | 0.07% |
799
| – | – |
2020 Q4
1 quarter
|
|
110
Edwards Lifesciences
EW
$49.9B
| $293K | 0.07% |
3,501
-34
| -1% | -$2.87K |
2018 Q2
11 quarters
|
|
111
NBT Bancorp
NBTB
$2.64B
| $289K | 0.07% |
7,250
+250
| +4% | +$9.2K |
2020 Q4
1 quarter
|
|
112
KeyCorp
KEY
$21.3B
| $287K | 0.07% |
14,345
-1,148
| -7% | -$22.2K |
2020 Q3
2 quarters
|
|
113
Plug Power
PLUG
$1.93B
| $286K | 0.07% |
7,977
-2,005
| -20% | -$103K |
2020 Q3
2 quarters
|
|
114
Pfizer
PFE
$169B
| $267K | 0.06% |
7,379
+975
| +15% | +$34.6K |
2020 Q4
1 quarter
|
|
115
Coca-Cola
KO
$404B
| $256K | 0.06% |
4,850
-29,934
| -86% | -$1.51M |
2020 Q2
3 quarters
|
|
116
Southern Company
SO
$105B
| $253K | 0.06% |
4,071
| – | – |
2020 Q4
1 quarter
|
|
117
Charles Schwab
SCHW
$159B
| $249K | 0.06% |
+3,813
| New | +$231K |
2021 Q1
0 quarters
|
|
118
Schwab U.S Small- Cap ETF
SCHA
$21.3B
| $245K | 0.06% |
9,848
| – | – |
2020 Q4
1 quarter
|
|
119
Vanguard Global ex-US Real Estate ETF
VNQI
$3.25B
| $239K | 0.06% |
4,295
-200
| -4% | -$10.9K |
2020 Q4
1 quarter
|
|
|
120
Schwab US Large-Cap Growth ETF
SCHG
$62.8B
| $234K | 0.05% |
14,416
-134,696
| -90% | -$2.19M |
2017 Q2
15 quarters
|
|
121
State Street SPDR S&P Dividend ETF
SDY
$21.5B
| $234K | 0.05% |
+1,981
| New | +$222K |
2021 Q1
0 quarters
|
|
122
Pioneer Bancorp
PBFS
$425M
| $227K | 0.05% |
19,500
| – | – |
2020 Q3
2 quarters
|
|
123
American Express
AXP
$212B
| $207K | 0.05% |
+1,460
| New | +$193K |
2021 Q1
0 quarters
|
|
124
CSX Corp
CSX
$90.2B
| $200K | 0.05% |
+6,231
| New | +$190K |
2021 Q1
0 quarters
|
|
125
Trustco Bank Corp NY
TRST
$925M
| $85K | 0.02% |
2,318
-39
| -2% | -$1.37K |
2020 Q3
2 quarters
|
|
Similar funds
CANC
HP
Fagan Associates's Q1 2021 Portfolio in Review
As of Q1 2021, Fagan Associates held 127 positions worth $428M, up 7.4% from $398M the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Fagan Associates deployed $17M of net new capital in Q1 2021, opening 11 new positions and adding to 41 existing holdings. Its largest new stake was Ally Financial: 89,710 shares worth $4.06M.
By sector, the portfolio is most concentrated in Miscellaneous at 24% of assets, up from 23% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Ulta Beauty, an estimated $3.93M trimmed.
- Fagan Associates's largest Q1 2021 buy was Ally Financial: 89,710 shares worth $4.06M.
- Fagan Associates added most to Vertex Pharmaceuticals in Q1 2021, an estimated $3.2M increase.
- Fagan Associates's biggest Q1 2021 reduction was Ulta Beauty, cutting an estimated $3.93M.
- Fagan Associates fully exited Kirkland Lake Gold Ltd Ordinary in Q1 2021, selling an estimated $2.61M.
- Fagan Associates's ten largest holdings make up 40% of its $428M portfolio in Q1 2021.
- Fagan Associates opened 11 new positions and closed 2 in Q1 2021.
- Fagan Associates's portfolio value rose 7.4% quarter-over-quarter to $428M.
Based on Fagan Associates's 13F filing for Q1 2021, filed 6 May 2021.